Filter
2071
Text search:
medicine
product
Featured
Recommendations
194
New Publications
515
Language
Document type
No document type
1014
Studies & Reports
411
Guidelines
348
Manuals
141
Strategic & Response Plan
75
Fact sheets
37
Training Material
27
Situation Updates
10
Resource Platforms
6
Infographics
2
Countries / Regions
Global
97
India
72
Ethiopia
58
Kenya
54
South Africa
51
Nigeria
48
Uganda
39
Latin America and the Carribbean
36
Ghana
33
Nepal
31
Liberia
30
Tanzania
30
Malawi
30
Sierra Leone
29
Western and Central Europe
28
Bangladesh
27
Zambia
25
Rwanda
25
Myanmar / Burma
24
Namibia
22
Philippines
19
South–East Asia Region
17
Africa
16
Zimbabwe
15
Syria
13
Ukraine
13
Lesotho
13
Germany
11
East and Southern Africa
11
Congo, Democratic Republic of
10
Cambodia
10
Mozambique
10
Asia
10
Indonesia
9
Eswatini/ Swaziland
9
West and Central Africa
9
Eastern Europe
9
Haiti
8
Botswana
8
Middle East and North Africa
8
Guinea
7
Burkina Faso
7
Senegal
7
Cameroon
7
Vietnam
7
Pakistan
6
China
6
USA
5
South Sudan
5
Afghanistan
5
Thailand
5
Brazil
5
Albania
5
Sudan
4
Benin
4
Yemen
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Russia
4
United Kingdom
4
Somalia
3
Lebanon
3
Turkey
3
North Macedonia
3
Paraguay
3
Venezuela
3
Moldova
3
Japan
3
Jordan
2
Malaysia
2
Central African Republic
2
Angola
2
Madagascar
2
Fiji
2
Southern Africa
2
Laos
2
Tajikistan
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
North America
2
Jamaica
2
Spain
2
Bosnia and Herzegovina
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Chad
1
Gambia
1
Argentina
1
Peru
1
Ecuador
1
Libya
1
Guatemala
1
Sri Lanka
1
Chile
1
Other region
1
Poland
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
757
Clinical Guidelines
181
Public Health
115
Key Resources
83
Women & Child Health
77
Pharmacy & Technologies
55
Capacity Building
26
Toolboxes
HIV
138
AMR
138
COVID-19
137
Pharmacy
131
Mental Health
114
TB
114
NTDs
90
Planetary Health
81
NCDs
43
Caregiver
42
Malaria
42
Ebola & Marburg
41
Rapid Response
34
Global Health Education
34
Disability
33
Health Financing Toolbox
32
Conflict
27
Specific Hazards
18
Refugee
17
2.0 Rapid Response
14
Zika
13
Natural Hazards
12
Cholera
7
Social Ethics
5
Polio
3
The 2020 Report analyzes global health spending for 190 countries from 2000 to 2018 and provides insights as to the health spending trajectory from the MDG era to the SDG era prior to the crisis of 2020. The report shows that global spending on health continually rose between 2000 and 2018 and reach
...
Information and Approaches for developing Country Settings
In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.
As part of our commitment to the fight against NCDs, Nigeria was signatory to the political declaration at the UN General Assembly High Level Meeting on NCDs in September 2011. Thus, the purpose of this document is to develop and ensure the implementation of policies and p
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para
...
In 2018, the Intergovernmental Panel on Climate Change announced that to restrict global temperature rise to 1·5°C, greenhouse gas emissions must decrease 45% by 2030 compared with 2010, and reach net zero by 2050.1
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...